Improving predictability of clinical trial outcomes
Improving predictability of clinical trial outcomes
Development of clinical decision support tools for physicians and patients
Identifying and applying molecular subgrouping in colorectal cancer
Treatment of melanoma in Latin America
Highlights from EHA 2013
Challenges facing haematologists treating acute myeloid leukaemia
JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms
Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms
Vemurafenib and ipilimumab for metastatic melanoma
Monoclonal antibodies and targeting them against cancer cells in lymphoma
Neo-angiogenesis and pathological angiogenesis in targeted molecules
Role of microenvironment and stroma in cancer therapy